A pilot study of the continuous glucose monitoring system - Clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects
A pilot study of the continuous glucose monitoring system - Clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects
复制标题
DOI：
10.2337/diacare.24.12.2030
复制
发表时间：
2001-12-01
期刊：
影响因子：
16.2
通讯作者：
Pitukcheewanont, P
中科院分区：
文献类型：
--
作者：
Kaufman, FR;Gibson, LC;Pitukcheewanont, P
目的：确定连续血糖监测系统（CGMS） （MiniMed, Sylmar， CA）是否可以用于临床决策，以及它是否对儿童I型糖尿病受试者的血糖有影响。研究设计和方法：招募有HbA(1c)≥8.0%且有管理问题的儿科受试者（n = 35），或HbA(1c)≥8.0%的严重或夜间低血糖发作或低血糖不意识发作（n = 12）。共有47例患者，平均HbA（1c）值为8.6 +/- 1.6%（平均年龄11.8 +/- 4.6岁，最年轻2.7岁，糖尿病病程5.5 +/- 3.5年）接受3 - 4次胰岛素注射/天（n = 24）或胰岛素泵治疗（n = 23）， CGMS随访平均69.5 +/- 28小时。比较高（>150 mg/dl）和低(
OBJECTIVE - To determine whether the continuous glucose monitoring system (CGMS) (MiniMed, Sylmar, CA) could be used to make clinical decisions and whether it has an impact on glycemia in pediatric type I diabetic subjects.RESEARCH DESIGN AND METHODS - Pediatric subjects were recruited if they had HbA(1c) >8.0% with management problems (n = 35) or episodes of severe or nocturnal hypoglycemia or hypoglycemia unawareness associated with HbA(1c) less than or equal to8.0% (n = 12). A total of 47 patients with a mean HbA(1c) value of 8.6 +/- 1.6% (mean age 11.8 +/- 4.6 years, youngest 2.7 years, and diabetes duration 5.5 +/- 3.5 years) on three to four insulin injections/day (n = 24) or insulin pump therapy (n = 23) were followed with the CGMS for a mean of 69.5 +/- 28 h. Comparisons were made between the number of high (>150 mg/dl) and low (